Determining the effect of outpatient vaginal administration of misoprostol to reduce the rate of postpartum pregnancy and successful induction of labor
Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
General information
90
empty
90
empty
The primary version did not mention the secondary outcomes. In this edition, the secondary outcomes have also been completed.
The primary version did not mention the secondary outcomes. In this edition, the secondary outcomes have also been completed.
empty
درنسخه اولیه به پیامدهای ثانویه اشاره نشده بود.دراین ویرایش پیامدهای ثانویه نیز تکمیل شده اند.
درنسخه اولیه به پیامدهای ثانویه اشاره نشده بود.دراین ویرایش پیامدهای ثانویه نیز تکمیل شده اند.
empty
empty
Secondary outcomes
#1
empty
admission time to 2nd stage interval
admission time to 2nd stage interval
empty
زمان بستری تا مرحله دوم زایمان
زمان بستری تا مرحله دوم زایمان
empty
Admission time and stage 2
Admission time and stage 2
empty
زمان بستری و شروع مرحله دوم
زمان بستری و شروع مرحله دوم
empty
time interval (hour)
time interval (hour)
empty
فاصله زمانی براساس ساعت
فاصله زمانی براساس ساعت
#2
empty
First administration to delivery interval
First administration to delivery interval
empty
فاصله تجویز دارو تازمان زایمان
فاصله تجویز دارو تازمان زایمان
empty
39th week, delivery time
39th week, delivery time
empty
39هفته وزایمان
39هفته وزایمان
empty
time interval (hour)
time interval (hour)
empty
فاصله زمانی براساس ساعت
فاصله زمانی براساس ساعت
#3
empty
duration of stage 2
duration of stage 2
empty
مدت مرحله دوم زایمان
مدت مرحله دوم زایمان
empty
full diatation , fetal delivery
full diatation , fetal delivery
empty
دیلاتاسیون کامل تاخروج نوزاد
دیلاتاسیون کامل تاخروج نوزاد
empty
time interval (min)
time interval (min)
empty
فاصله زمانی براساس دقیقه
فاصله زمانی براساس دقیقه
#4
empty
additional interventions
additional interventions
empty
مداخلات تکمیلی
مداخلات تکمیلی
empty
Delivery time
Delivery time
empty
زمان زایمان
زمان زایمان
empty
additional doses of oxytocin and misoprostol
additional doses of oxytocin and misoprostol
empty
بررسی دوزهای تکمیلی میزوپروستول و اکسی توسین
بررسی دوزهای تکمیلی میزوپروستول و اکسی توسین
#5
empty
final route of delivery
final route of delivery
empty
روش زایمان
روش زایمان
empty
delivery time
delivery time
empty
زمان زایمان
زمان زایمان
empty
normal vaginal delivery or cesarian section duo to documents
normal vaginal delivery or cesarian section duo to documents
empty
زایمان طبیعی یاسزارین براساس پرونده
زایمان طبیعی یاسزارین براساس پرونده
#6
empty
maternal complication
maternal complication
empty
عوارض مادری
عوارض مادری
empty
delivery time
delivery time
empty
زمان زایمان
زمان زایمان
empty
Any complication that has been registered in the case file for the mother
Any complication that has been registered in the case file for the mother
empty
هرگونه عارضه ای که برای مادر درپرونده ثبت شده باشد
هرگونه عارضه ای که برای مادر درپرونده ثبت شده باشد
#7
empty
apgar score
apgar score
empty
نمره آپگار
نمره آپگار
empty
first and 5th minutes after delivery
first and 5th minutes after delivery
empty
دقیقه اول و پنجم بعدزایمان
دقیقه اول و پنجم بعدزایمان
empty
apgaar score scale
apgaar score scale
empty
براساس جدول آپگار
براساس جدول آپگار
#8
empty
meconial staining
meconial staining
empty
دفع مکونیوم
دفع مکونیوم
empty
delivery time
delivery time
empty
زمان زایمان
زمان زایمان
empty
observation at delivery time
observation at delivery time
empty
مشاهده موقع زایمان
مشاهده موقع زایمان
#9
empty
gestational age at admission
gestational age at admission
empty
سن بارداری زمان بستری
سن بارداری زمان بستری
empty
Admission time
Admission time
empty
زمان بستری
زمان بستری
empty
gestational age according first trimester sonography
gestational age according first trimester sonography
empty
سن بارداری به هفته براساس سونوگرافی سه ماهه اول بارداری
سن بارداری به هفته براساس سونوگرافی سه ماهه اول بارداری
Protocol summary
Study aim
Determine the effect of outpatient misoprostol administration on postmenopausal pregnancy and induction success
Design
Randomized clinical trial.
Settings and conduct
In this study, 90 primigravida women, referring to the Ghaem Hospital are randomly assigned to the intervention and control groups. 25 micrograms of vaginal misoprostol is administered and membrane stripping will be performed in the intervention group. If necessary, the same intervention will be done at 40th week of gestational age and then every other day until the 41th week (up to a maximum of 5 doses of misoprostol).
In the control group, the membrane stripping is done on the same days for pregnant women.
Participants/Inclusion and exclusion criteria
Entry criteria: Single-strike pregnancy, primitive gravid, cephalic presentation, normal amniotic fluid (AFI greater than or equal to 5 cm), no history of medical and obstetric and metabolic diseases, Bishop score less than 8 / reactive nst /
maternal age between 18 to 40 years / no contrindication for misoprostol / no bad history of midwifery, fetal death or infertility / lack of evidence for placenta previa or adhesion / without uterine scar / No evidence of macrosomia / No evidence of IUGR.
Exit criteria: lack of patient referral / diagnosis of pre-eclampsia after including the study
Intervention groups
Mothers of intervention group receive 25 microgram of vaginal misoprostol and membrane stripping.
Mothers of control group only receive membrane stripping.
Main outcome variables
Gestational age at delivery /the interval between the intervention and delivery / the interval between admission to delivery / maternal and neonatal outcomes including Apgar score / NICU admission / the need for resusciation /the rate of meconium aspiration / the rate of cesarean section.
General information
Reason for update
The primary version did not mention the secondary outcomes. In this edition, the secondary outcomes have also been completed.
Acronym
IRCT registration information
IRCT registration number:IRCT20180215038742N1
Registration date:2018-04-09, 1397/01/20
Registration timing:registered_while_recruiting
Last update:2021-08-24, 1400/06/02
Update count:2
Registration date
2018-04-09, 1397/01/20
Registrant information
Name
Farnaz Hadavi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3841 3007
Email address
hadavif951@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-04-09, 1397/01/20
Expected recruitment end date
2018-07-22, 1397/04/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Determining the effect of outpatient vaginal administration of misoprostol to reduce the rate of postpartum pregnancy and successful induction of labor
Public title
Determine the effect of prescribing of misoprostol in reducing postpartum pregnancy and delivery success
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Pregnant women with gestational age 39 weeks
Primigravida
Between 18 - 40 years old
Singletone pregnancy
Normal fetal heart rate
Cephalic presentation (Vertex)
AFI equal or more than 5 cm
No history of medical or midwifery disorders
Bishop score less than 8
Reactive NST
Without uterine contractions
Exclusion criteria:
Macrosomia
Sensitivity to PGs
Uterin wall scar
Preeclampsia or blood pressure more than 140/90 mmhg
PROM
Vaginal Bleeding
IUGR fetus
Age
From 18 years old to 40 years old
Gender
Female
Phase
3
Groups that have been masked
No information
Sample size
Target sample size:
90
Randomization (investigator's opinion)
Randomized
Randomization description
Patients are assigned to intervention or control group, using a series of opaque envelopes prepared by using random numbers generated from www.randomizer.org.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Mashhad University of Medical Sciences
Street address
Central organization of the University, Knowledge and Health Township, Fakouri Blvd
City
Mashhad
Province
Razavi Khorasan
Postal code
91778-99191
Approval date
2017-12-13, 1396/09/22
Ethics committee reference number
IR.MUMS.fm.REC.1396.550
Health conditions studied
1
Description of health condition studied
Post-term Pregnancy
ICD-10 code
O48.0
ICD-10 code description
Post-term pregnancy
Primary outcomes
1
Description
Delivery rate before 41th week of gestational age.
Timepoint
39th week, 40th week and then every other day.
Method of measurement
newborn birth
Secondary outcomes
1
Description
admission time to 2nd stage interval
Timepoint
Admission time and stage 2
Method of measurement
time interval (hour)
2
Description
First administration to delivery interval
Timepoint
39th week, delivery time
Method of measurement
time interval (hour)
3
Description
duration of stage 2
Timepoint
full diatation , fetal delivery
Method of measurement
time interval (min)
4
Description
additional interventions
Timepoint
Delivery time
Method of measurement
additional doses of oxytocin and misoprostol
5
Description
final route of delivery
Timepoint
delivery time
Method of measurement
normal vaginal delivery or cesarian section duo to documents
6
Description
maternal complication
Timepoint
delivery time
Method of measurement
Any complication that has been registered in the case file for the mother
7
Description
apgar score
Timepoint
first and 5th minutes after delivery
Method of measurement
apgaar score scale
8
Description
meconial staining
Timepoint
delivery time
Method of measurement
observation at delivery time
9
Description
gestational age at admission
Timepoint
Admission time
Method of measurement
gestational age according first trimester sonography
Intervention groups
1
Description
Intervention group: Vaginal misoprostol (25 micrograms) in pregnant women and membrane stripping
Category
Treatment - Drugs
2
Description
Control group: membrane stripping
Category
N/A
Recruitment centers
1
Recruitment center
Name of recruitment center
Quaem hospital
Full name of responsible person
Farnaz Hadavi
Street address
Dr. Ali Shariati Sq., Ahmadabad Ave.
City
Mashhad
Province
Razavi Khorasan
Postal code
99199-91766
Phone
+98 51 3840 0000
Email
farnazhadavi@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mohsen Tafaghodi
Street address
University compound, Azadi sqr.
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 8888
Email
med.faculty@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Farnaz Hadavi
Position
Assistant
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
University compound, Azadi square
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 8888
Fax
Email
hadavif951@mums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Sedighe Ayati
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
University compound, Azadi square
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 8888
Fax
Email
hadavif951@mums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Farnaz Hadavi
Position
Assistant
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
University compound, Azadi square
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 8888
Fax
Email
hadavif951@mums.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Not applicable
Analytic Code
Not applicable
Data Dictionary
Not applicable
Title and more details about the data/document
All anonymous data are shareable.
When the data will become available and for how long
One year after publication
To whom data/document is available
Academic researchers
Under which criteria data/document could be used
For meta-analysis studies
From where data/document is obtainable
Email address
What processes are involved for a request to access data/document